Did Fulcrum Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - FULCAccesswire • 09/20/24
Bronstein, Gewirtz & Grossman, LLC Encourages Fulcrum Therapeutics, Inc. (FULC) Stockholders to Inquire about Securities InvestigationAccesswire • 09/20/24
The Schall Law Firm Has Launched An Investigation Into Possible Securities Law Violations By Fulcrum Therapeutics, Inc. And Investors Are Invited To Take PartAccesswire • 09/20/24
ATTENTION Fulcrum Therapeutics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your RightsAccesswire • 09/19/24
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulcrum Therapeutics, Inc. (FULC) and Encourages Investors to Learn More About the InvestigationAccesswire • 09/19/24
Fulcrum Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - FULCAccesswire • 09/19/24
Fulcrum Therapeutics Inc Is Being Inquired Into For Securities Fraud And Affected Shareholders Should Contact The Schall Law FirmAccesswire • 09/18/24
Fulcrum Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - FULCAccesswire • 09/18/24
Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationAccesswire • 09/18/24
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Fulcrum Therapeutics, Inc. (FULC)Accesswire • 09/17/24
The Schall Law Firm Seeks Investor Contributions To An Investigation Into Fulcrum Therapeutics, Inc. For Possible Securities Related InfractionsAccesswire • 09/17/24
FULC STOCK ALERT: Levi & Korsinsky Notifies Fulcrum Therapeutics, Inc. Investors of an Ongoing InvestigationAccesswire • 09/17/24
Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationAccesswire • 09/17/24
Fulcrum Therapeutics Inc May Have Defrauded Shareholders And Those With Losses Are Urged To Take Part In The Schall Law Firm's InquiryAccesswire • 09/17/24
Fulcrum Therapeutics (FULC) Loses -65.58% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 09/16/24
ATTENTION FULC SHAREHOLDERS: Investors who lost money on Fulcrum Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigationAccesswire • 09/16/24
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulcrum Therapeutics, Inc. (FULC) and Encourages Stockholders to Learn More About the InvestigationAccesswire • 09/16/24
Fulcrum Therapeutics, Inc. Being Investigated on Behalf of Fulcrum Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details.Accesswire • 09/15/24
The Schall Law Firm Is Looking Into Whether Fulcrum Therapeutics, Inc. Violated Securities Laws And Affected Investors Should Reach OutAccesswire • 09/15/24
Bronstein, Gewirtz & Grossman, LLC Encourages Fulcrum Therapeutics, Inc. (FULC) Investors to Inquire about Securities InvestigationAccesswire • 09/15/24
Did Fulcrum Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- FULCAccesswire • 09/15/24
Shareholders In Fulcrum Therapeutics Inc Are Invited To Join The Schall Law Firm's Investigation Into Possible Securities FraudAccesswire • 09/14/24
The Schall Law Firm Is Looking Into Fulcrum Therapeutics, Inc. For Possible Securities Related Infractions And Impacted Investors Should Reach OutAccesswire • 09/13/24
Fulcrum Therapeutics, Inc. (FULC) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their RightsAccesswire • 09/13/24
